Personnel and Equipment for Monitoring and Resusciation and Risks From Concomitant Use with Opioid Analgesics

Personnel and Equipment for Monitoring and Resuscitation

Risks From Concomitant Use With Opioid Analgesics and Other Sedative-Hypnotics

  • Concomitant use of benzodiazepines, including BYFAVO, and opioid analgesics may result in profound sedation, respiratory depression, coma, and death. The sedative effect of intravenous BYFAVO can be accentuated by concomitantly administered CNS depressant medications, including other benzodiazepines and propofol. Continuously monitor patients for respiratory depression and depth of sedation [see WARNINGS AND PRECAUTIONS (5.2), DRUG INTERACTIONS (7.1)] .

Patient counseling

Package inserts

Additional information

Keywords: Byfavo
Updated: August 2020